ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
+1.8%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$326M
AUM Growth
+$326M
(-7.8%)
Cap. Flow
-$28.9M
Cap. Flow
% of AUM
-8.87%
Top 10 Holdings %
Top 10 Hldgs %
35.02%
Holding
109
New
17
Increased
26
Reduced
40
Closed
25
Top Buys
| 1 |
Sabra Healthcare REIT
SBRA
|
$12.2M |
| 2 |
Danaher
DHR
|
$11.8M |
| 3 |
Pediatrix Medical
MD
|
$7.61M |
| 4 |
Johnson & Johnson
JNJ
|
$7.35M |
| 5 |
TVTY
Tivity Health, Inc. Common Stock
TVTY
|
$6.25M |
Top Sells
| 1 |
Becton Dickinson
BDX
|
$8.29M |
| 2 |
UnitedHealth
UNH
|
$6.6M |
| 3 |
BCR
CR Bard Inc.
BCR
|
$6.29M |
| 4 |
iRhythm Technologies
IRTC
|
$6.29M |
| 5 |
Thermo Fisher Scientific
TMO
|
$6.24M |
Sector Composition
| 1 | Healthcare | 83.72% |
| 2 | Real Estate | 3.74% |
| 3 | Financials | 3% |
| 4 | Industrials | 0.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
UnitedHealth
UNH
$281B
| $4.46M | 1.35% | 22,772 -33,712 | -60% | -$6.6M |
|
27
Viatris
VTRS
$12.3B
| $4.12M | 1.25% | 131,400 -4,200 | -3% | -$132K |
|
|
ENTL
28
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $3.85M | 1.17% | 208,771 +130,171 | +166% | +$2.4M |
|
29
Hologic
HOLX
$14.9B
| $3.79M | 1.15% | 103,203 +84,774 | +460% | +$3.11M |
|
|
NVRO
30
DELISTED
NEVRO CORP.
NVRO
| $3.59M | 1.09% | 39,461 -17,800 | -31% | -$1.62M |
|
31
Stryker
SYK
$150B
| $3.57M | 1.08% | 25,104 -37,162 | -60% | -$5.28M |
|
32
Henry Schein
HSIC
$8.44B
| $3.44M | 1.04% | +41,900 | New | +$3.44M |
|
33
Vertex Pharmaceuticals
VRTX
$100B
| $3.33M | 1.01% | +21,900 | New | +$3.33M |
|
34
ANI Pharmaceuticals
ANIP
$2.03B
| $3.14M | 0.95% | 59,900 +44,300 | +284% | +$2.33M |
|
35
Cigna
CI
$80.3B
| $3.12M | 0.95% | 16,700 +9,300 | +126% | +$1.74M |
|
|
WAGE
36
DELISTED
WageWorks, Inc.
WAGE
| $3.1M | 0.94% | +51,100 | New | +$3.1M |
|
37
Sarepta Therapeutics
SRPT
$1.78B
| $3.05M | 0.93% | +67,300 | New | +$3.05M |
|
|
EVHC
38
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $3.05M | 0.92% | 67,860 -75,058 | -53% | -$3.37M |
|
39
Insmed
INSM
$28.8B
| $2.98M | 0.9% | +95,400 | New | +$2.98M |
|
40
Cencora
COR
$56.5B
| $2.79M | 0.85% | 33,740 -12,400 | -27% | -$1.03M |
|
|
AERI
41
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $2.78M | 0.84% | 57,188 +4,158 | +8% | +$202K |
|
|
42
Becton Dickinson
BDX
$55.3B
| $2.74M | 0.83% | 14,001 -42,300 | -75% | -$8.29M |
|
43
Jazz Pharmaceuticals
JAZZ
$7.75B
| $2.7M | 0.82% | 18,450 -41,150 | -69% | -$6.02M |
|
|
WBA
44
DELISTED
Walgreens Boots Alliance
WBA
| $2.66M | 0.81% | 34,464 -13,400 | -28% | -$1.03M |
|
45
Nektar Therapeutics
NKTR
$568M
| $2.62M | 0.79% | 109,300 +66,500 | +155% | +$1.6M |
|
46
Puma Biotechnology
PBYI
$254M
| $2.56M | 0.78% | 21,400 +2,100 | +11% | +$252K |
|
47
Incyte
INCY
$16.5B
| $2.52M | 0.76% | 21,600 +1,400 | +7% | +$163K |
|
48
Zoetis
ZTS
$69.3B
| $2.52M | 0.76% | 39,500 +24,000 | +155% | +$1.53M |
|
|
CELG
49
DELISTED
Celgene Corp
CELG
| $2.38M | 0.72% | 16,300 -34,900 | -68% | -$5.09M |
|
|
50
iRhythm Technologies
IRTC
$5.46B
| $2.3M | 0.7% | 44,300 -121,200 | -73% | -$6.29M |
|